Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10918807 | Radiotherapy and Oncology | 2012 | 5 Pages |
Abstract
The fidelity of radiation planning and execution detailed in protocol to actual therapy is heterogeneous, with a mean per-protocol rate of 65%. As clinical trials evolve, available technology should permit efficient pre-treatment review processes, thus facilitating compliance to protocol therapy. These analyses should also permit prospective analysis of outcome measures by compliance to therapy.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Christopher G. Willett, Jennifer Moughan, Elizabeth O'Meara, James M. Galvin, Christopher H. Crane, Kathryn Winter, Denise Manfredi, Tyvin A. Rich, Rachel Rabinovitch, Robert Lustig, Mitchell Machtay, Walter J. Curran,